RUXIN MICHAEL I 4
4 · Avant Diagnostics, Inc · Filed Sep 11, 2018
Insider Transaction Report
Form 4
RUXIN MICHAEL I
Chief Executive Officer
Transactions
- Award
Series A Preferred Stock
2018-08-23$1.00/sh+25,000$25,000→ 25,000 total→ Common Stock
Footnotes (1)
- [F1]The Reporting Person purchased the Series A Preferred Stock from the Company on August 23, 2018. The Series A Preferred Stock has no expiration date and upon consummation of a reverse stock split of the Issuer's common stock such that after consummation of such reverse stock split there are approximately 15,000,000 shares of the Issuer's common stock outstanding, the holders shall take all necessary steps with the Issuer to exchange all outstanding shares of Series A Preferred Stock into shares of the Issuer's common stock at a rate to be agreed upon between the parties. The holders of Series A Preferred Stock collectively shall always constitute 50.1% of the voting power of the Issuer.